Julia Schueler In vivo Tumorbiology Oncotest GmbH Biography Publications Institution JoVE Articles Julia Schueler has not added a biography. If you are Julia Schueler and would like to personalize this page please email our Author Liaison for assistance. Publications BEZ235 (PIK3/mTOR Inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma Cells Translational Oncology. Jun, 2016 | Pubmed ID: 27267837 Capturing Complex Tumour Biology in Vitro: Histological and Molecular Characterisation of Precision Cut Slices Scientific Reports. 2015 | Pubmed ID: 26647838 Patient-derived Cell Models As Preclinical Tools for Genome-directed Targeted Therapy Oncotarget. Sep, 2015 | Pubmed ID: 26296973 Intratibial Injection of Human Multiple Myeloma Cells in NOD/SCID IL-2Rγ(null) Mice Mimics Human Myeloma and Serves As a Valuable Tool for the Development of Anticancer Strategies PloS One. 2013 | Pubmed ID: 24223204 Human Vδ1 γδ T Cells Expanded from Peripheral Blood Exhibit Specific Cytotoxicity Against B-cell Chronic Lymphocytic Leukemia-derived Cells Cytotherapy. Jul, 2011 | Pubmed ID: 21314241 Uitputting van de Muis Cellen van geënte, humane tumoren verbetert Downstream Analyse van Target Cellen David J. Agorku1, Stefan Tomiuk1, Kerstin Klingner2, Stefan Wild1, Silvia Rüberg1, Lisa Zatrieb1, Andreas Bosio1, Julia Schueler2, Olaf Hardt1 1R&D Reagents, Miltenyi Biotec GmbH, 2In vivo Tumorbiology, Oncotest GmbH JoVE 54259 Médecine
Uitputting van de Muis Cellen van geënte, humane tumoren verbetert Downstream Analyse van Target Cellen David J. Agorku1, Stefan Tomiuk1, Kerstin Klingner2, Stefan Wild1, Silvia Rüberg1, Lisa Zatrieb1, Andreas Bosio1, Julia Schueler2, Olaf Hardt1 1R&D Reagents, Miltenyi Biotec GmbH, 2In vivo Tumorbiology, Oncotest GmbH JoVE 54259 Médecine